FDA Counterfeit Screening Tool Gets Field Test In Ghana; Corning Prepares Device For Mass Production
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA currently employs the CD3 in its laboratories and at a number of international mail facilities and other points of entry to the U.S. to screen cosmetics, foods, medical devices and cigarettes, as well as drugs.
You may also be interested in...
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in an interview.
FDA’s New Criminal Investigations Chief Wants Global Reach
Recently appointed Office of Criminal Investigations Director George Karavetsos talks about expanding the global presence of his office to protect product safety in the U.S. in an interview.
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in interview with “The Pink Sheet.”